These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 12653137)

  • 1. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.
    Tsao J; Barbour AG; Luke CJ; Fikrig E; Fish D
    Vector Borne Zoonotic Dis; 2001; 1(1):65-74. PubMed ID: 12653137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.
    Voordouw MJ; Tupper H; Önder Ö; Devevey G; Graves CJ; Kemps BD; Brisson D
    Vector Borne Zoonotic Dis; 2013 Apr; 13(4):203-14. PubMed ID: 23428088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantification of pathogen load in a vector.
    Ornstein K; Barbour AG
    Vector Borne Zoonotic Dis; 2006; 6(1):103-12. PubMed ID: 16584333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.
    Gipson CL; de Silva AM
    Infect Immun; 2005 Mar; 73(3):1644-7. PubMed ID: 15731064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
    de Silva AM; Telford SR; Brunet LR; Barthold SW; Fikrig E
    J Exp Med; 1996 Jan; 183(1):271-5. PubMed ID: 8551231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks.
    de Silva AM; Zeidner NS; Zhang Y; Dolan MC; Piesman J; Fikrig E
    Infect Immun; 1999 Jan; 67(1):30-5. PubMed ID: 9864192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
    Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM
    Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of Borrelia burgdorferi infectivity in white-footed mice for the tick vector Ixodes scapularis under laboratory and field conditions in Ontario.
    Lindsay LR; Barker IK; Surgeoner GA; McEwen SA; Campbell GD
    J Wildl Dis; 1997 Oct; 33(4):766-75. PubMed ID: 9391960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential efficacy of passive immunisation against infection by Lyme disease spirochaetes transmitted by partially fed vector ticks.
    Shih CM; Liu LP
    J Med Microbiol; 1998 Sep; 47(9):773-9. PubMed ID: 9736159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of outer surface protein A by Borrelia burgdorferi during transmission from infected mammals to feeding ticks is insufficient to trigger OspA seroconversion.
    Woodman ME; Cooley AE; Stevenson B
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):277-82. PubMed ID: 18793197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Borrelia burgdorferi OspA in Ixodes scapularis larvae by an antigen-capture enzyme-linked immunosorbent assay.
    Mannelli A; Fish D; Daniels TJ; Kharitonenkov I; Tun H; Cozzolino AC; Bucher DJ
    New Microbiol; 1997 Oct; 20(4):355-9. PubMed ID: 9385607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Demonstration of Reservoir Competence of the White-Footed Mouse, Peromyscus leucopus (Rodentia: Cricetidae), for the Lyme Disease Spirochete, Borrelia mayonii (Spirochaetales: Spirochaetaceae).
    Parise CM; Breuner NE; Hojgaard A; Osikowicz LM; Replogle AJ; Eisen RJ; Eisen L
    J Med Entomol; 2020 May; 57(3):927-932. PubMed ID: 31819966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks.
    de Silva AM; Fish D; Burkot TR; Zhang Y; Fikrig E
    Infect Immun; 1997 Aug; 65(8):3146-50. PubMed ID: 9234767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W; Gern L; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A relapsing fever group spirochete transmitted by Ixodes scapularis ticks.
    Scoles GA; Papero M; Beati L; Fish D
    Vector Borne Zoonotic Dis; 2001; 1(1):21-34. PubMed ID: 12653133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.
    Pal U; de Silva AM; Montgomery RR; Fish D; Anguita J; Anderson JF; Lobet Y; Fikrig E
    J Clin Invest; 2000 Aug; 106(4):561-9. PubMed ID: 10953031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.
    Meirelles Richer L; Aroso M; Contente-Cuomo T; Ivanova L; Gomes-Solecki M
    Clin Vaccine Immunol; 2011 Nov; 18(11):1809-16. PubMed ID: 21918116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.